This one-hour, on-demand video module provides Kentucky pharmacists and technicians with up-to-date information on the opioid epidemic and changes in opioid antagonist products. Learners will gain a better understanding of the role of opioid antagonists (e.g., naloxone, nalmefene) in reversing opioid overdose deaths, and products that are available by prescription or over-the-counter. This presentation aims to help members of the pharmacy team decrease barriers to opioid antagonist access and educate patients on opioid overdose response and reversal. This module will provide the most recent information that will facilitate availability of opioid antagonists from pharmacies and give Kentucky communities the tools they need to combat opioid overdose deaths.
|
This ACPE-accredited continuing pharmacy education activity (UAN 0022-0000-23-006-H08-P/T) is designed to meet the Kentucky Board of Pharmacy continuing education regulatory requirement for pharmacists to complete 1 hour of CPE on the opioid epidemic or opioid use disorder as outlined in 201 KAR 2:015.
|
|---|
Faculty
 Monica Roberts, PharmD
Academic Detailing Pharmacist
Substance Use Priority Research Area
University of Kentucky
|
|
|
Monica Roberts, PharmD is an academic detailing pharmacist working with the HEALing Communities Study Kentucky. Dr. Roberts graduated from the University of Kentucky College of Pharmacy in 2017 and completed the University of Kentucky College of Pharmacy Community Pharmacy Residency Program with the Kroger Louisville Division in 2018. She has over 6 years’ experience working in various roles in retail community pharmacies. Prior to her pharmacy career, she worked in journalism and publishing as a copy editor, page designer, and technical writer.
|
|
|
Disclosure: Dr. Roberts has no relevant financial relationships with ineligible companies to disclose.
|
|
|
Planners and Reviewers
The planners, organizers, and others in control of the content of this activity have no relevant financial relationships with ineligible companies to disclose.
|
|
ACPE Reviewer
Adrienne Matson, PharmD, BCPS
Disclosure: Dr. Matson has no relevant financial relationships with ineligible companies to disclose.
|
|
Peer Reviewer
Trish Freeman, RPh, PhD, FAPhA, FNAP
Disclosure: Dr. Freeman has no relevant financial relationships with ineligible companies to disclose.
|
Learning Objectives
Pharmacist
- Review the mechanism of action for opioid antagonists and their role in reducing opioid overdose deaths.
- Discuss existing and emerging prescription and over-the-counter opioid antagonists and considerations for product selection.
- Describe the role of pharmacists in increasing access to opioid antagonists and supporting efforts to reduce rates of opioid overdose.
Pharmacy Technician
- Review the mechanism of action for opioid antagonists and their role in reducing opioid overdose deaths.
- List opioid antagonist products that are available by prescription and over the counter.
- Describe the role of pharmacy technicians in assisting patients with obtaining opioid antagonists and assisting the pharmacist with dispensing under protocol.
Agenda
- Pre-test (5 min)
- Presentation (45 min)
- Post-test and Evaluation (10 min)
Requirements for CE Credit
To claim credit for this activity, participants must:
1. Complete the pre-test
2. View the online video module in its entirety
3. Pass the post-test with a score of 70% or higher
4. Complete the activity evaluation
Upon successful completion participant CE credit will be directly uploaded to CPE Monitor.
Please be sure to verify your NABP e-Profile ID and date of birth (month/day) are correct under your learner profile in Learning Express prior to submitting your evaluation.
Fee
$0.00
CE Hours
1.00
CE Units
0.100
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
- Pharmacy Technicians
Accreditation(s)
The University of Kentucky College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Support
This activity was supported by the National Institutes of Health through the NIH HEAL Initiative under award number UM1DA049406. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or its NIH HEAL Initiative. For more information regarding the NIH HEAL Initiative visit: NIH HEALing Communities Study and www.HealTogetherKY.org.
System Requirements
Please ensure the computer system you plan to use meets the following minimum requirements:
- Operating System: Windows 10 or higher, macOS Sierra (10.12) or higher
- Internet Browser: Chrome 30 or higher, Firefox 27 or higher, Microsoft Edge, Safari 9 or higher
- Internet connection: Cable, High-speed DSL, and any other medium that is internet accessible
- Peripherals: Computer speakers or headphones
- Media Viewing Requirements: Adobe Reader, HTML5
Education Disclaimer
The author(s) of this continuing education activity have made reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific evidence at the time of publication. However, because information regarding medications, treatment guidelines, legal/regulatory issues and other healthcare information is subject to constant change, the participant is advised to always confirm practice resources before applying any learned information in practice. Activities accredited by the University of Kentucky College of Pharmacy are intended solely for purposes of supplementing health care professionals’ knowledge. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of The University of Kentucky College of Pharmacy.
For questions regarding this activity, please contact the UK CoP Continuing Professional Development Office at pharmacyCPD@uky.edu